BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 30946192)

  • 1. Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
    Tan TL; Foltz C; Huang R; Chen AF; Higuera C; Siqueira M; Hansen EN; Sing DC; Parvizi J
    J Bone Joint Surg Am; 2019 Apr; 101(7):589-599. PubMed ID: 30946192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
    Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
    Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
    Singh G; Prentice HA; Winston BA; Kroger EW
    J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
    Kahlenberg CA; Richardson SS; Schairer WW; Sculco PK
    J Bone Joint Surg Am; 2018 Aug; 100(16):1366-1372. PubMed ID: 30106817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
    Richardson SS; Schairer WW; Sculco PK; Bostrom MP
    Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection.
    Huang R; Buckley PS; Scott B; Parvizi J; Purtill JJ
    J Arthroplasty; 2015 Sep; 30(9 Suppl):39-41. PubMed ID: 26182982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?
    Raphael IJ; Tischler EH; Huang R; Rothman RH; Hozack WJ; Parvizi J
    Clin Orthop Relat Res; 2014 Feb; 472(2):482-8. PubMed ID: 23817755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
    Gonzalez Della Valle A; Shanaghan KA; Nguyen J; Liu J; Memtsoudis S; Sharrock NE; Salvati EA
    Bone Joint J; 2020 Jul; 102-B(7_Supple_B):71-77. PubMed ID: 32600195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.
    Baumgartner C; Maselli J; Auerbach AD; Fang MC
    J Gen Intern Med; 2019 Oct; 34(10):2038-2046. PubMed ID: 31236894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty.
    Shohat N; Ludwick L; Sutton R; Chisari E; Parvizi J
    J Arthroplasty; 2022 May; 37(5):953-957. PubMed ID: 35026368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
    Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
    JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis.
    Peng HM; Chen X; Wang YO; Bian YY; Feng B; Wang W; Weng XS; Qian WW
    Orthop Surg; 2021 Feb; 13(1):260-266. PubMed ID: 33448672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
    Hovik O; Amlie EJ; Jenssen KK
    J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.